Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation.
Riwes MM, Golob JL, Magenau J, Shan M, Dick G, Braun T, Schmidt TM, Pawarode A, Anand S, Ghosh M, Maciejewski J, King D, Choi S, Yanik G, Geer M, Hillman E, Lyssiotis CA, Tewari M, Reddy P. Riwes MM, et al. Nat Med. 2023 Nov;29(11):2805-2813. doi: 10.1038/s41591-023-02587-y. Epub 2023 Oct 19. Nat Med. 2023. PMID: 37857710 Free PMC article. Clinical Trial.
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.
Magenau J, Jaglowski S, Uberti J, Farag SS, Riwes MM, Pawarode A, Anand S, Ghosh M, Maciejewski J, Braun T, Devenport M, Lu S, Banerjee B, DaSilva C, Devine S, Zhang MJ, Burns LJ, Liu Y, Zheng P, Reddy P. Magenau J, et al. Among authors: riwes mm. Blood. 2024 Jan 4;143(1):21-31. doi: 10.1182/blood.2023020250. Blood. 2024. PMID: 37647633 Clinical Trial.
Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients.
Coda J, Raser K, Anand SM, Ghosh M, Gregg K, Li J, Maciejewski JJ, Pawarode A, Riwes MM, Tillman C, Polk A, Kandarpa M, Talpaz M, Choi SW, Yanik GA, Magenau JM, Pianko MJ. Coda J, et al. Among authors: riwes mm. Bone Marrow Transplant. 2023 Apr;58(4):446-451. doi: 10.1038/s41409-022-01906-0. Epub 2022 Dec 22. Bone Marrow Transplant. 2023. PMID: 36550198 No abstract available.
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.
Magenau JM, Goldstein SC, Peltier D, Soiffer RJ, Braun T, Pawarode A, Riwes MM, Kennel M, Antin JH, Cutler CS, Ho VT, Alyea EP 3rd, Parkin BL, Yanik GA, Choi SW, Lewis EC, Dinarello CA, Koreth J, Reddy P. Magenau JM, et al. Among authors: riwes mm. Blood. 2018 Mar 22;131(12):1372-1379. doi: 10.1182/blood-2017-11-815746. Epub 2018 Feb 2. Blood. 2018. PMID: 29437593 Free PMC article. Clinical Trial.
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission.
Magenau JM, Braun T, Reddy P, Parkin B, Pawarode A, Mineishi S, Choi S, Levine J, Li Y, Yanik G, Kitko C, Churay T, Frame D, Riwes MM, Harris A, Bixby D, Couriel DR, Goldstein SC. Magenau JM, et al. Among authors: riwes mm. Ann Hematol. 2015 Jun;94(6):1033-41. doi: 10.1007/s00277-015-2349-4. Epub 2015 Mar 19. Ann Hematol. 2015. PMID: 25784222